In the spring of 2015, Kevin Gosnell was diagnosed with ALS. His world turned upside down.
A few short months later, Kevin visited the ALS Therapy Development Institute, not just to learn about the mission and work of the organization, but to share with us his vision of bringing key players in the ALS space together to find a treatment for ALS within four years.
Such a partnership had never existed.
Yesterday, the ALS Therapy Development Institute, Massachusetts General Hospital/Harvard Medical School and the University of Massachusetts Medical School partnered to create ALS ONE. The partnership is focused on one goal: identify a treatment for ALS. ALS ONE is led by Dr. Robert Brown (UMass), Dr. Merit Cudkowicz (MGH) and Dr. Steve Perrin (ALS TDI). Together, this team has identified the strongest therapeutic opportunities in ALS and are working together as partners to expedite progress toward a treatment, including the sharing of ideas and division of responsibility to advance research projects forward. The ALS ONE model is also set up to contribute a percentage of funds to Compassionate Care ALS, and the clinics at UMass and MGH, to assist people living with the disease until a treatment is available.
© ALS TDI